{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T10:52:24Z","timestamp":1794135144077,"version":"4.8.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"34","license":[{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/17\/2532884"],"award-info":[{"award-number":["PG\/17\/2532884"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/13\/5\/30177"],"award-info":[{"award-number":["RE\/13\/5\/30177"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/18\/6134217"],"award-info":[{"award-number":["RE\/18\/6134217"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["107715\/Z\/15\/Z"],"award-info":[{"award-number":["107715\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Heart, Lung, and Blood Institute, National Institutes of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Endothelin-1 (ET-1) is a potent vasoconstrictor peptide linked to vascular diseases through a common intronic gene enhancer [(rs9349379-G allele), chromosome 6 (PHACTR1\/EDN1)]. We performed a multimodality investigation into the role of ET-1 and this gene variant in the pathogenesis of coronary microvascular dysfunction (CMD) in patients with symptoms and\/or signs of ischaemia but no obstructive coronary artery disease (CAD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Three hundred and ninety-one patients with angina were enrolled. Of these, 206 (53%) with obstructive CAD were excluded leaving 185 (47%) eligible. One hundred and nine (72%) of 151 subjects who underwent invasive testing had objective evidence of CMD (COVADIS criteria). rs9349379-G allele frequency was greater than in contemporary reference genome bank control subjects [allele frequency 46% (129\/280 alleles) vs. 39% (5551\/14380); P\u2009=\u20090.013]. The G allele was associated with higher plasma serum ET-1 [least squares mean 1.59\u2009pg\/mL vs. 1.28\u2009pg\/mL; 95% confidence interval (CI) 0.10\u20130.53; P\u2009=\u20090.005]. Patients with rs9349379-G allele had over double the odds of CMD [odds ratio (OR) 2.33, 95% CI 1.10\u20134.96; P\u2009=\u20090.027]. Multimodality non-invasive testing confirmed the G allele was associated with linked impairments in myocardial perfusion on stress cardiac magnetic resonance imaging at 1.5\u2009T (N\u2009=\u2009107; GG 56%, AG 43%, AA 31%, P\u2009=\u20090.042) and exercise testing (N\u2009=\u200987; \u22123.0 units in Duke Exercise Treadmill Score; \u22125.8 to \u22120.1; P\u2009=\u20090.045). Endothelin-1 related vascular mechanisms were assessed ex vivo using wire myography with endothelin A receptor (ETA) antagonists including zibotentan. Subjects with rs9349379-G allele had preserved peripheral small vessel reactivity to ET-1 with high affinity of ETA antagonists. Zibotentan reversed ET-1-induced vasoconstriction independently of G allele status.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We identify a novel genetic risk locus for CMD. These findings implicate ET-1 dysregulation and support the possibility of precision medicine using genetics to target oral ETA antagonist therapy in patients with microvascular angina.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration<\/jats:title>\n                  <jats:p>ClinicalTrials.gov: NCT03193294.<\/jats:p>\n                  <jats:p\/>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehz915","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T04:34:52Z","timestamp":1575952492000},"page":"3239-3252","source":"Crossref","is-referenced-by-count":124,"title":["Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4009-6652","authenticated-orcid":false,"given":"Thomas J","family":"Ford","sequence":"first","affiliation":[{"name":"British Heart Foundation Glasgow Cardiovascular Research Centre , Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 9DH, UK"},{"name":"Department of Cardiology, Gosford Hospital, NSW , Australia"},{"name":"Faculty of Medicine, University of Newcastle, NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5047-0885","authenticated-orcid":false,"given":"David","family":"Corcoran","sequence":"additional","affiliation":[{"name":"British Heart Foundation Glasgow Cardiovascular Research Centre , Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 9DH, UK"},{"name":"West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital , Clydebank G81 4DY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3869-5808","authenticated-orcid":false,"given":"Sandosh","family":"Padmanabhan","sequence":"additional","affiliation":[{"name":"British Heart Foundation Glasgow Cardiovascular Research Centre , Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 9DH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4022-5880","authenticated-orcid":false,"given":"Alisha","family":"Aman","sequence":"additional","affiliation":[{"name":"British Heart Foundation Glasgow Cardiovascular Research Centre , Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 9DH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rocchiccioli","sequence":"additional","affiliation":[{"name":"British Heart Foundation Glasgow Cardiovascular Research Centre , Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 9DH, UK"},{"name":"West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital , Clydebank G81 4DY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3906-1025","authenticated-orcid":false,"given":"Richard","family":"Good","sequence":"additional","affiliation":[{"name":"British Heart Foundation Glasgow Cardiovascular Research Centre , Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 9DH, UK"},{"name":"West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital , Clydebank G81 4DY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5135-3322","authenticated-orcid":false,"given":"Margaret","family":"McEntegart","sequence":"additional","affiliation":[{"name":"British Heart Foundation Glasgow Cardiovascular Research Centre , Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 9DH, UK"},{"name":"West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital , Clydebank G81 4DY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9254-7040","authenticated-orcid":false,"given":"Janet J","family":"Maguire","sequence":"additional","affiliation":[{"name":"Experimental Medicine and Immunotherapeutics, University of Cambridge , Level 6, Addenbrooke's Centre for Clinical Investigation (ACCI), Box 110, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1579-6294","authenticated-orcid":false,"given":"Stuart","family":"Watkins","sequence":"additional","affiliation":[{"name":"West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital , Clydebank G81 4DY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany","family":"Eteiba","sequence":"additional","affiliation":[{"name":"West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital , Clydebank G81 4DY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aadil","family":"Shaukat","sequence":"additional","affiliation":[{"name":"West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital , Clydebank G81 4DY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Lindsay","sequence":"additional","affiliation":[{"name":"West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital , Clydebank G81 4DY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6557-8298","authenticated-orcid":false,"given":"Keith","family":"Robertson","sequence":"additional","affiliation":[{"name":"West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital , Clydebank G81 4DY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4708-3926","authenticated-orcid":false,"given":"Stuart","family":"Hood","sequence":"additional","affiliation":[{"name":"West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital , Clydebank G81 4DY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"McGeoch","sequence":"additional","affiliation":[{"name":"Laboratory for Advanced Cardiovascular Imaging, National Heart , Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"McDade","sequence":"additional","affiliation":[{"name":"West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital , Clydebank G81 4DY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Yii","sequence":"additional","affiliation":[{"name":"British Heart Foundation Glasgow Cardiovascular Research Centre , Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 9DH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1604-2593","authenticated-orcid":false,"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[{"name":"British Heart Foundation Glasgow Cardiovascular Research Centre , Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 9DH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yueh","family":"Hsu","sequence":"additional","affiliation":[{"name":"Laboratory for Advanced Cardiovascular Imaging, National Heart , Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E","family":"Arai","sequence":"additional","affiliation":[{"name":"Laboratory for Advanced Cardiovascular Imaging, National Heart , Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7842-3463","authenticated-orcid":false,"given":"Keith G","family":"Oldroyd","sequence":"additional","affiliation":[{"name":"British Heart Foundation Glasgow Cardiovascular Research Centre , Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 9DH, UK"},{"name":"West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital , Clydebank G81 4DY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhian M","family":"Touyz","sequence":"additional","affiliation":[{"name":"British Heart Foundation Glasgow Cardiovascular Research Centre , Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 9DH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2096-3117","authenticated-orcid":false,"given":"Anthony P","family":"Davenport","sequence":"additional","affiliation":[{"name":"Experimental Medicine and Immunotherapeutics, University of Cambridge , Level 6, Addenbrooke's Centre for Clinical Investigation (ACCI), Box 110, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4547-8636","authenticated-orcid":false,"given":"Colin","family":"Berry","sequence":"additional","affiliation":[{"name":"British Heart Foundation Glasgow Cardiovascular Research Centre , Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 9DH, UK"},{"name":"West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital , Clydebank G81 4DY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,23]]},"reference":[{"key":"2022102614305906500_ehz915-B1","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM196705112761904","article-title":"Paradox of normal selective coronary arteriograms in patients considered to have unmistakable coronary heart disease","volume":"276","author":"Likoff","year":"1967","journal-title":"N Engl J Med"},{"key":"2022102614305906500_ehz915-B2","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur Heart J"},{"key":"2022102614305906500_ehz915-B3","doi-asserted-by":"crossref","first-page":"e0125374.","DOI":"10.1371\/journal.pone.0125374","article-title":"Renal function and coronary microvascular dysfunction in women with symptoms\/signs of ischemia","volume":"10","author":"Mohandas","year":"2015","journal-title":"PLoS One"},{"key":"2022102614305906500_ehz915-B4","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/eurheartj\/ehx001","article-title":"Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis: the PRognostic Importance of MIcrovascular Dysfunction in Aortic Stenosis (PRIMID AS) Study","volume":"38","author":"Singh","year":"2017","journal-title":"Eur Heart J"},{"key":"2022102614305906500_ehz915-B5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jacc.2018.05.049","article-title":"Coronary microvascular dysfunction and cardiovascular risk in obese patients","volume":"72","author":"Bajaj","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102614305906500_ehz915-B6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","article-title":". International standardization of diagnostic criteria for microvascular angina","volume":"250","author":"Ong","year":"2018","journal-title":"Int J Cardiol"},{"key":"2022102614305906500_ehz915-B7","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa0907272","article-title":"Low diagnostic yield of elective coronary angiography","volume":"362","author":"Patel","year":"2010","journal-title":"N Engl J Med"},{"key":"2022102614305906500_ehz915-B8","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","article-title":"Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial","volume":"72","author":"Ford","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102614305906500_ehz915-B9","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","article-title":"Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease","volume":"8","author":"Sara","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102614305906500_ehz915-B10","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCULATIONAHA.113.004096","article-title":"Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries","volume":"129","author":"Ong","year":"2014","journal-title":"Circulation"},{"key":"2022102614305906500_ehz915-B11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/CIRCULATIONAHA.116.023266","article-title":"Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease","volume":"135","author":"Taqueti","year":"2017","journal-title":"Circulation"},{"key":"2022102614305906500_ehz915-B12","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.jacc.2004.12.084","article-title":"Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease","volume":"47","author":"Bairey Merz","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2022102614305906500_ehz915-B13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/clc.22894","article-title":"Why names matter for women: MINOCA\/INOCA (myocardial infarction\/ischemia and no obstructive coronary artery disease)","volume":"41","author":"Pacheco Claudio","year":"2018","journal-title":"Clin Cardiol"},{"key":"2022102614305906500_ehz915-B14","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/HYPERTENSIONAHA.106.083303","article-title":"Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B","volume":"49","author":"Halcox","year":"2007","journal-title":"Hypertension"},{"key":"2022102614305906500_ehz915-B15","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/CIRCULATIONAHA.109.900191","article-title":"Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management","volume":"121","author":"Lanza","year":"2010","journal-title":"Circulation"},{"key":"2022102614305906500_ehz915-B16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijcard.2003.06.025","article-title":"Elevated plasma endothelin-1 levels in coronary sinus during rapid right atrial pacing in patients with slow coronary flow","volume":"97","author":"Pekdemir","year":"2004","journal-title":"Int J Cardiol"},{"key":"2022102614305906500_ehz915-B17","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.cell.2017.06.049","article-title":"A genetic variant associated with five vascular diseases is a distal regulator of endothelin-1 gene expression","volume":"170","author":"Gupta","year":"2017","journal-title":"Cell"},{"key":"2022102614305906500_ehz915-B18","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"key":"2022102614305906500_ehz915-B19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2018.03.010","article-title":"Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial","volume":"201","author":"Ford","year":"2018","journal-title":"Am Heart J"},{"key":"2022102614305906500_ehz915-B20","first-page":"42","article-title":"Self-administration of a questionnaire on chest pain and intermittent claudication","volume":"31","author":"Rose","year":"1977","journal-title":"Br J Prev Soc Med"},{"key":"2022102614305906500_ehz915-B21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jacc.2018.09.085","article-title":"Association of the PHACTR1\/EDN1 genetic locus with spontaneous coronary artery dissection","volume":"73","author":"Adlam","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022102614305906500_ehz915-B22","first-page":"2565","article-title":"International standardization of diagnostic criteria for vasospastic angina","volume":"38","author":"Beltrame","year":"2017","journal-title":"Eur Heart J"},{"key":"2022102614305906500_ehz915-B23","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","article-title":"Stratified medical therapy using invasive coronary function testing in angina: CorMicA Trial","volume":"72","author":"Ford","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102614305906500_ehz915-B24","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.CIR.89.3.1013","article-title":"Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography","volume":"89","author":"De Bruyne","year":"1994","journal-title":"Circulation"},{"key":"2022102614305906500_ehz915-B25","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1161\/01.CIR.0000017199.09457.3D","article-title":"Coronary thermodilution to assess flow reserve: validation in humans","volume":"105","author":"Pijls","year":"2002","journal-title":"Circulation"},{"key":"2022102614305906500_ehz915-B26","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/CIRCULATIONAHA.113.008507","article-title":"Effects of sex on coronary microvascular dysfunction and cardiac outcomes","volume":"129","author":"Murthy","year":"2014","journal-title":"Circulation"},{"key":"2022102614305906500_ehz915-B27","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1161\/01.CIR.0000080700.98607.D1","article-title":"Novel index for invasively assessing the coronary microcirculation","volume":"107","author":"Fearon","year":"2003","journal-title":"Circulation"},{"key":"2022102614305906500_ehz915-B28","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/CIRCULATIONAHA.114.012636","article-title":"Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease","volume":"131","author":"Lee","year":"2015","journal-title":"Circulation"},{"key":"2022102614305906500_ehz915-B29","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/01.CIR.92.9.2426","article-title":"Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans","volume":"92","author":"Lerman","year":"1995","journal-title":"Circulation"},{"key":"2022102614305906500_ehz915-B30","doi-asserted-by":"crossref","first-page":"e002485.","DOI":"10.1161\/JAHA.112.002485","article-title":"Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease","volume":"1","author":"Ohba","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"2022102614305906500_ehz915-B31","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1093\/eurheartj\/ehy529","article-title":"Systemic microvascular dysfunction in microvascular and vasospastic angina","volume":"39","author":"Ford","year":"2018","journal-title":"Eur Heart J"},{"key":"2022102614305906500_ehz915-B32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"2022102614305906500_ehz915-B33","doi-asserted-by":"crossref","first-page":"35.","DOI":"10.1186\/1532-429X-15-35","article-title":"Standardized image interpretation and post processing in cardiovascular magnetic resonance: society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing","volume":"15","author":"Schulz-Menger","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"2022102614305906500_ehz915-B34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jcmg.2018.01.005","article-title":"Diagnostic performance of fully automated pixel-wise quantitative myocardial perfusion imaging by cardiovascular magnetic resonance","volume":"11","author":"Hsu","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022102614305906500_ehz915-B35","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/01.CIR.98.16.1622","article-title":"Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups","volume":"98","author":"Shaw","year":"1998","journal-title":"Circulation"},{"key":"2022102614305906500_ehz915-B36","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJM199109193251204","article-title":"Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease","volume":"325","author":"Mark","year":"1991","journal-title":"N Engl J Med"},{"key":"2022102614305906500_ehz915-B37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/hrt.2006.108167","article-title":"Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)","volume":"93","author":"Woodward","year":"2005","journal-title":"Heart"},{"key":"2022102614305906500_ehz915-B38","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/cvr\/cvx103","article-title":"Enhanced endothelin-1\/Rho-kinase signalling and coronary microvascular dysfunction in hypertensive myocardial hypertrophy","volume":"113","author":"Tsai","year":"2017","journal-title":"Cardiovasc Res"},{"key":"2022102614305906500_ehz915-B39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijcard.2017.05.010","article-title":"Non-invasive assessment of microvascular dysfunction in patients with microvascular angina","volume":"248","author":"Jaarsma","year":"2017","journal-title":"Int J Cardiol"},{"key":"2022102614305906500_ehz915-B40","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2019.08.1056","article-title":"Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease","volume":"74","author":"Suda","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022102614305906500_ehz915-B41","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.jcin.2017.08.059","article-title":"Physiological predictors of acute coronary syndromes: emerging insights from the plaque to the vulnerable patient","volume":"10","author":"Ford","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102614305906500_ehz915-B42","article-title":"Coronary endothelial function and spontaneous coronary artery dissection","author":"Waterbury","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2022102614305906500_ehz915-B43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamacardio.2016.0962","article-title":"Association of elevated plasma endothelin-1 levels with pulmonary hypertension, mortality, and heart failure in African American Individuals: the Jackson Heart Study","volume":"1","author":"Jankowich","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2022102614305906500_ehz915-B44","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/hrt.74.6.620","article-title":"Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms","volume":"74","author":"Kaski","year":"1995","journal-title":"Br Heart J"},{"key":"2022102614305906500_ehz915-B45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/pr.115.011833","article-title":"Endothelin","volume":"68","author":"Davenport","year":"2016","journal-title":"Pharmacol Rev"},{"key":"2022102614305906500_ehz915-B46","first-page":"741","article-title":"Quantification of endothelin receptor subtypes in peripheral tissues reveals downregulation of ET(A) receptors in ET(B)-deficient mice","volume":"231","author":"Kuc","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"2022102614305906500_ehz915-B47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/HYPERTENSIONAHA.115.07031","article-title":"Smooth muscle endothelin B receptors regulate blood pressure but not vascular function or neointimal remodeling","volume":"69","author":"Miller","year":"2017","journal-title":"Hypertension"},{"key":"2022102614305906500_ehz915-B48","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s12350-013-9756-5","article-title":"Physiology of endothelin in producing myocardial perfusion heterogeneity: a mechanistic study using Darusentan and positron emission tomography","volume":"20","author":"Johnson","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"2022102614305906500_ehz915-B49","first-page":"1427","article-title":"Clinical evaluation of a new concept: resting myocardial perfusion heterogeneity quantified by Markovian analysis of PET identifies coronary microvascular dysfunction and early atherosclerosis in 1,034 subjects","volume":"46","author":"Johnson","year":"2005","journal-title":"J Nucl Med"},{"key":"2022102614305906500_ehz915-B50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0735-1097(99)00224-7","article-title":"Elevated endothelin concentrations are associated with reduced coronary vasomotor responses in patients with chest pain and normal coronary arteriograms","volume":"34","author":"Cox","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2022102614305906500_ehz915-B51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijcard.2019.04.008","article-title":"Plasma endothelin-1 and adrenomedullin are associated with coronary artery function and cardiovascular outcomes in humans","volume":"291","author":"Theuerle","year":"2019","journal-title":"Int J Cardiol"},{"key":"2022102614305906500_ehz915-B52","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jacc.2013.10.007","article-title":"Heart failure with preserved ejection fraction: a heterogenous disorder with multifactorial pathophysiology","volume":"63","author":"Kitzman","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022102614305906500_ehz915-B53","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.jacc.2018.07.106","article-title":"Coronary physiology beyond coronary flow reserve in microvascular angina: JACC state-of-the-art review","volume":"72","author":"Gould","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102614305906500_ehz915-B54","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0735-1097(98)00451-3","article-title":"Value of exercise treadmill testing in women","volume":"32","author":"Alexander","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2022102614305906500_ehz915-B55","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijcard.2003.11.045","article-title":"Relation between Duke treadmill score and coronary flow reserve using transesophageal Doppler echocardiography in patients with microvascular angina","volume":"98","author":"Youn","year":"2005","journal-title":"Int J Cardiol"},{"key":"2022102614305906500_ehz915-B56","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1161\/01.CIR.98.21.2235","article-title":"Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease","volume":"98","author":"Wenzel","year":"1998","journal-title":"Circulation"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/34\/3239\/46645327\/eurheartj_41_34_3239.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/34\/3239\/46645327\/eurheartj_41_34_3239.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T15:32:20Z","timestamp":1666798340000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/41\/34\/3239\/5714931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,23]]},"references-count":56,"journal-issue":{"issue":"34","published-online":{"date-parts":[[2020,1,23]]},"published-print":{"date-parts":[[2020,9,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehz915","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9,7]]},"published":{"date-parts":[[2020,1,23]]}}}